Bis[3,5-bis(benzylidene)-4-oxo-1-piperidinyl]amides: a novel class of potent cytotoxins
- PMID: 21826795
- PMCID: PMC3344817
- DOI: 10.1002/cmdc.201100199
Bis[3,5-bis(benzylidene)-4-oxo-1-piperidinyl]amides: a novel class of potent cytotoxins
Abstract
The principal objective of this study was the examination of the theory of cytotoxic synergism. In this exploratory study, we tested the hypothesis that doubling the number of sites available for thiol alkylation in a series of candidate cytotoxins increases potency more than two-fold. This concept was verified in one-third of our comparisons using human Molt 4/C8 and CEM T-lymphocytes and murine L1210 cells. In addition, the significant potencies of various members of our compound series justified further studies. Molecular modeling revealed that relative locations of the amidic groups correlate with cytotoxicity. A potent cytotoxic compound, 1,2-bis(3,5-dibenzylidene-4-oxo-piperidin-1-yl)ethane-1,2-dione (1a) inhibited the growth of a large number of human tumor cell lines and displayed greater toxicity toward certain non-adherent cells than toward adherent neoplasms or fibroblasts. The mode of action of 1a includes induction of apoptosis and necrosis.
Copyright © 2011 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
Figures
) for 48 h using a previously described procedure.[20]
), necrotic (■), and viable (
) cells is indicated at the top of each bar graph. Two concentrations of 1a are shown on the x-axis. Note that twofold higher concentrations were utilized for the most resistant cell lines, SUP-T and CEM.
References
-
- Dimmock JR, Smith LM, Smith PJ. Can J Chem. 1980;58:984– 991.
-
- Aboul-Fodl T, El-Shorbagi AN, Hozien ZA, Sarham AW. Boll Chim Farm. 2000;139:228– 234. - PubMed
-
- Dimmock JR, Kumar P, Chen M, Quail JW, Yang J, Allen TM, Kao GY. Pharmazie. 1995;50:449– 453. - PubMed
-
- Dimmock JR, Raghavan SK, Logan BM, Bigam GE. Eur J Med Chem. 1983;18:248– 254.
-
- Mutus B, Wagner JD, Talpas CJ, Dimmock JR, Phillips OA, Reid RS. Anal Biochem. 1989;177:237– 243. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
